Six field experiments were conducted to investigate any interaction between pyroxasulfone and flumioxazin on soybean tolerance and control of multiple-herbicide-resistant (MHR) waterhemp in soybean during 2016 and 2017 in Ontario, Canada. There was a synergistic increase in soybean injury with the co-application of pyroxasulfone and flumioxazin at all rates evaluated at 2 weeks after emergence (WAE), the two highest rates evaluated (134/106 and 268/211 g ai ha−1) at 4 WAE, and the highest rate (268/211 g ai ha−1) evaluated at 8 WAE. Soybean injury with all pyroxasulfone and flumioxazin treatments was transient and had no adverse effect on soybean grain yield. Pyroxasulfone applied preemergence (PRE) at 45, 89, 134, and 268 g ai ha−1 controlled MHR waterhemp up to 72, 89, 92, and 95%, respectively. Flumioxazin applied PRE at 35, 70, 106, and 211 g ai ha−1 controlled MHR waterhemp up to 78, 90, 93, and 96%, respectively. Pyroxasulfone/flumioxazin applied PRE at 45/35, 89/70, 134/106, and 268/211 g ai ha−1 controlled MHR waterhemp up to 92, 96, 98 and 100%, respectively. There were no significant antagonistic or synergistic interactions for the control of MHR waterhemp with pyroxasulfone/flumioxazin at rates evaluated except at 268/211 g ai ha−1 which provided a synergistic increase in MHR waterhemp control at 4 WAE. The MHR waterhemp biomass and density reductions followed a similar trend as visible control. Pyroxasulfone/flumioxazin at 268/211 g ai ha−1 caused a synergistic response in biomass reduction (9% difference). Based on these results, there is an additive increase in MHR waterhemp control and potential for synergistic soybean injury with the co-application of pyroxasulfone plus flumioxazin.
Two studies were conducted to ascertain the biologically-effective-dose (BED) of flumioxazin and pyroxasulfone for multiple-herbicide-resistant (MHR) waterhemp [Amaranthus tuberculatus (Moq.) Sauer] control in soybean [Glycine max (L.) Merr.] in southwestern Ontario, Canada, during 2016 and 2017. In the flumioxazin study, the predicted flumioxazin doses for 50, 80 and 90% MHR A. tuberculatus control were 19, 37, and 59 g ai ha−1 at 2 weeks after application (WAA) and 31, 83, and 151 g ai ha−1, respectively, at 12 WAA. The predicted flumioxazin doses to cause 5 and 10% soybean injury were 129 and 404 g ai ha−1, respectively at 2 weeks after emergence (WAE), and the predicted flumioxazin doses to obtain 50, 80, and 95% of the weed-free control plot’s yield were determined to be 3, 14, and 65 g ai ha−1, respectively. In the pyroxasulfone study, the predicted pyroxasulfone doses that provided 50, 80, and 90% MHR A. tuberculatus visual control were 25, 50, and 88 g ai ha−1 at 2 WAA and 41, 109, and 274 g ai ha−1 at 12 WAA, respectively. 117 g ai ha−1 was the dose of pyroxasulfone predicted for 80% reduction in MHR A. tuberculatus density and the predicted doses of pyroxasulfone for 80 and 90% reduction in A. tuberculatus biomass were 204 and 382 g ai ha−1, respectively. The predicted doses of pyroxasulfone that caused 5 and 10% injury in soybean at 2 WAE were 585 and 698 g ai ha−1, respectively. 6, 24 and 112 g ai ha−1 was the predicted doses of pyroxasulfone required to obtain 50, 80, and 95% yield relative to the weed-free plots, respectively. Flumioxazin and pyroxasulfone applied PRE at the appropriate doses provided early-season MHR A. tuberculatus control in soybean.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.